Skip to main content
SpringerLink
Log in

Diet and Lifestyle Factors in the Etiology and Management of Polycystic Ovary Syndrome

  • Chapter
Insulin Resistance and Polycystic Ovarian Syndrome

Part of the book series: Contemporary Endocrinology ((COE))

  • 1375 Accesses

Abstract

Conditions of overweight and obesity contribute to reproductive dysfunction. Appropriate dietary strategies and exercise can reverse these disorders. This chapter covers the causes and consequences of lifestyle disorders in polycystic ovary syndrome and relevant interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Frisch RE. Fatness, menarche, and female fertility. Perspect Biol 1985;28:611–633.

    CAS  Google Scholar 

  2. Frisch RE. Body fat, menarche, fitness and fertility. Human Reprod 1987;2:521–533.

    CAS  Google Scholar 

  3. Correa H, Jacoby J. Nutrition and fertility: some iconoclastic results. Am J Clin Nutr 1978;31:1431–1436.

    CAS  PubMed  Google Scholar 

  4. Pasquali R, Casimirri F, Colella P, Melchionda N. Body fat distribution and weight loss in obese women [letter]. Am J Clin Nutr 1989;49:185–187.

    CAS  PubMed  Google Scholar 

  5. Pasquali R, Casimirri F. The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin Endocrinol (Oxf) 1993;39:1–16.

    Article  CAS  Google Scholar 

  6. Zachow RJ, Magoffin DA. Direct intraovarian effects of leptin: impairment of the synergistic action of insulin-like growth factor-I on follicle-stimulating hormone-dependent estradiol-17 beta production by rat ovarian granulosa cells. Endocrinology 1997;138:847–850.

    Article  CAS  PubMed  Google Scholar 

  7. Chapman IM, Wittert GA, Norman RJ. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters. Clin Endocrinol (Oxf) 1997;46:175–181.

    Article  CAS  Google Scholar 

  8. Mantzoros CS, Dunaif A, Flier JS. Leptin concentrations in the polycystic ovary syndrome [see comments]. J Clin Endocrinol Metab 1997;82:1687–1691.

    Article  CAS  PubMed  Google Scholar 

  9. Nader S, Riad Gabriel MG, Saad MF. The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women. J Clin Endocrinol Metab 1997;82:3074–3077.

    Article  CAS  PubMed  Google Scholar 

  10. Moran LJ, Clifton PM, Wittert GA, et al. Ghrelin and measures of satiety are altered in polycystic ovary syndrome but not differentially affected by diet composition. J Clin Endocrinol Metab 2004; 89:3337–3344.

    Article  CAS  PubMed  Google Scholar 

  11. Mitchell GW, Rogers J. The influence of weight reduction on amenorrhea in obese women. N Engl J Med 1953;249:835–837.

    PubMed  Google Scholar 

  12. Hartz AJ, Barboriak PN, Wong A, Katayama KP, Rimm A. The association of obesity with infertility and related menstural abnormalities in women. Int J Obes 1979;3:57–73.

    CAS  PubMed  Google Scholar 

  13. Lake JK, Power C, Cole TJ. Women’s reproductive health: the role of body mass index in early and adult life. Int J Obes Relat Metab Disord 1997;21:432–438.

    Article  CAS  PubMed  Google Scholar 

  14. Balen AH, Conway GS, Kaltsas G, et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Human Reprod 1995;10:2107–2111.

    CAS  Google Scholar 

  15. Kiddy DS, Sharp PS, White DM, et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol (Oxf) 1990;32:213–220.

    Article  CAS  Google Scholar 

  16. Howe G, Westhoff C, Vessey M, Yeates D. Effects of age, cigarette smoking, and other factors on fertility: findings in a large prospective study. Br Med J (Clin Res Ed) 1985;290:1697–1700.

    Article  CAS  Google Scholar 

  17. Rich Edwards JW, Goldman MB, Willett WC, et al. Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol 1994;171:171–177.

    CAS  PubMed  Google Scholar 

  18. Grodstein F, Goldman MB, Cramer DW. Body mass index and ovulatory infertility. Epidemiology 1994;5:247–250.

    CAS  PubMed  Google Scholar 

  19. Zaadstra BM, Seidell JC, Van Noord PA, et al. Fat and female fecundity: prospective study of effect of body fat distribution on conception rates [see comments]. BMJ 1993;306:484–487.

    Article  CAS  PubMed  Google Scholar 

  20. Green BB, Weiss NS, Daling JR. Risk of ovulatory infertility in relation to body weight. Fertil Steril 1988;50:721–726.

    CAS  PubMed  Google Scholar 

  21. Hamilton-Fairley D, Kiddy D, Watson H, Paterson C, Franks S. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br J Obstet Gynaecol 1992;99:128–131.

    CAS  PubMed  Google Scholar 

  22. Bohrer M, Kemmann E. Risk factors for spontaneous abortion in menotropin-treated women. Fertil Steril 1987;48:571–575.

    CAS  PubMed  Google Scholar 

  23. Pettigrew R, Hamilton Fairley D. Obesity and female reproductive function. PMID 1997;53:341–358.

    CAS  Google Scholar 

  24. McClure N, McQuinn B, McDonald J, Kovacs GT, Healy DL, Burger HG. Body weight, body mass index, and age: predictors of menotropin dose and cycle outcome in polycystic ovarian syndrome? Fertil Steril 1992;58:622–624.

    CAS  PubMed  Google Scholar 

  25. Galtier Dereure F, Montpeyroux F, Boulot P, Bringer J, Jaffiol C. Weight excess before pregnancy: complications and cost. Int J Obes Relat Metab Disord 1995;19:443–448.

    CAS  PubMed  Google Scholar 

  26. Wang JX, Norman RJ. Risk factors for the deterioration of glucose metabolism in polycystic ovary syndrome. Reprod Biomed Online 2004;9:201–204.

    Article  CAS  PubMed  Google Scholar 

  27. Conway GS, Agrawal R, Betteridge DJ, Jacobs H. Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992;37:119–125.

    Article  CAS  Google Scholar 

  28. Dickey RP, Taylor SN, Curole DN, Rye PH, Lu PY, Pyrzak R. Relationship of clomiphene dose and patient weight to successful treatment. Human Reprod 1997;12:449–453.

    Article  CAS  Google Scholar 

  29. Friedman CI, Kim MH. Obesity and its effect on reproductive function. Clin Obstet Gynecol 1985;28:645–663.

    Article  CAS  PubMed  Google Scholar 

  30. Fuh KW, Wang X, Tai A, Wong I, Norman RJ. Intrauterine insemination: effect of the temporal relationship between the LH surge, hCG administration and insemination on pregnancy rates. Hum Reprod 1997;12:2162–2166.

    Article  CAS  PubMed  Google Scholar 

  31. Clark AM, Ledger W, Galletly C, et al. Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Human Reprod 1995;10:2705–2712.

    CAS  Google Scholar 

  32. Lewis CG, Warnes GM, Wang XJ, Matthews CD. Failure of body mass index or body weight to influence markedly the response to ovarian hyperstimulation in normal cycling women. Fertil Steril 1990;53:1097–1099.

    CAS  PubMed  Google Scholar 

  33. Wang JX, Davies MJ, Norman RJ. Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res 2002;10:551–554.

    Article  PubMed  Google Scholar 

  34. Norman RJ, Masters SC, Hague W, Beng C, Pannall P, Wang JX. Metabolic approaches to the subclassification of polycystic ovary syndrome. Fertil Steril 1995;63:329–335.

    CAS  PubMed  Google Scholar 

  35. Kaye SA, Folsom AR, Prineas RJ, Potter JD, Gapstur SM. The association of body fat distribution with lifestyle and reproductive factors in a population study of postmenopausal women. Int J Obes 1990;14:583–591.

    CAS  PubMed  Google Scholar 

  36. Norman RJ, Hague WM, Masters SC, Wang XJ. Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome. Hum Reprod 1995;10:2258–2261.

    CAS  PubMed  Google Scholar 

  37. Hollmann M, Runnebaum B, Gerhard I. Impact of waist-hip-ratio and body-mass-index on hormonal and metabolic parameters in young, obese women. Int J Obes Relat Metab Disord 1997;21:476–483.

    Article  CAS  PubMed  Google Scholar 

  38. Clark AM, Thornley B, Tomlinson L, Galletley C, Norman RJ. Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 1998;13:1502–1505.

    Article  CAS  PubMed  Google Scholar 

  39. Bates GW, Whitworth NS. Effect of body weight reduction on plasma androgens in obese, infertile women. Fertil Steril 1982;38:406–409.

    CAS  PubMed  Google Scholar 

  40. Pasquali R, Antenucci D, Casimirri F, et al. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 1989;68:173–179.

    Article  CAS  PubMed  Google Scholar 

  41. Kiddy DS, Hamilton Fairley D, Seppala M, et al. Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries; correlation with serum insulin and insulin-like growth factor-I. Clin Endocrinol (Oxf) 1989;31:757–763.

    Article  CAS  Google Scholar 

  42. Kiddy DS, Hamilton Fairley D, Bush A, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992;36:105–111.

    Article  CAS  Google Scholar 

  43. Pasquali R, Gambineri A, Biscotti D, et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 2000; 53:2767–2774.

    Article  Google Scholar 

  44. Bilenka B, Ben Shlomo I, Cozacov C, Gold CH, Zohar S. Fertility, miscarriage and pregnancy after vertical banded gastroplasty operation for morbid obesity. Acta Obstet Gynecol Scand Acta Obstetrica Gynecologica Scandinavia 1995;74:42–44.

    Article  CAS  Google Scholar 

  45. Toubro S, Astrup A. Randomised comparison of diets for maintaining obese subjects’ weight after major weight loss: ad lib, low fat, high carbohydrate diet vs fixed energy intake. BMJ 1997;314:29–34.

    CAS  PubMed  Google Scholar 

  46. Skov AR, Toubro S, Ronn B, Holm L, Astrup A. Randomized trial on protein vs carbohydrate in ad libitum reduced fat diet for the treatment of obesity. Int J Obes Relat Metab Disord 1999;23:528–536.

    Article  CAS  PubMed  Google Scholar 

  47. Ludwig DS. Dietary glycemic index and obesity. J Nutr 2000;130:280S–283S.

    CAS  PubMed  Google Scholar 

  48. Johnston CS, Tionn SL, Swan PD. High-protein, low-fat diets are effective for weight loss and favourably alter biomarkers in healthy adults. J Nutr 2004;134:586–591.

    CAS  PubMed  Google Scholar 

  49. Moran LJ, Noakes M, Clifton PM, Tomlinson L, Norman RJ. Dietary composition in restoring reproductive and metabolic physiology in polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:812–819.

    Article  CAS  PubMed  Google Scholar 

  50. Wolever TM, Jenkins DJ, Jenkins AL, Josse RG. The glycemic index: methodology and clinical implications. Am J Clin Nutr 1991;54:846–854.

    CAS  PubMed  Google Scholar 

  51. Jarvi AE, Karlstrom BE, Granfeldt YE, Bjork JE, Asp NG, Vessby BO. Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care 1999;22:10–18.

    Article  CAS  PubMed  Google Scholar 

  52. Acbay O, Gundogdu S. Can metformin reduce insulin resistance in polycystic ovary syndrome? Fertil Steril 1996;65:946–949.

    CAS  PubMed  Google Scholar 

  53. Holte J, Bergh T, Berne C, Berglund L, Lithell H. Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab 1994;78:1052–1058.

    Article  CAS  PubMed  Google Scholar 

  54. Holte J, Bergh T, Berne C, Wide L, Lithell H. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 1995;80:2586–2593.

    Article  CAS  PubMed  Google Scholar 

  55. Holte J. Disturbances in insulin secretion and sensitivity in women with the polycystic ovary syndrome. Baillieres. J Clin Endocrinol Metab 1996;10:221–247.

    CAS  Google Scholar 

  56. Dunaif A, Scott D, Finegood D, Quintana B, Whitcomb R. The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab 1996;81:3299–3306.

    Article  CAS  PubMed  Google Scholar 

  57. Ehrmann DA, Schneider DJ, Sobel BE, et al. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:2108–2116.

    Article  CAS  PubMed  Google Scholar 

  58. Guzick DS, Wing R, Smith D, Berga SL, Winters SJ. Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women. Fertil Steril 1994;61:598–604.

    CAS  PubMed  Google Scholar 

  59. Galletly C, Clark A, Tomlinson L, Blaney F. A group program for obese, infertile women: weight loss and improved psychological health. J Psychosom Obstet Gynaecol 1996;17:125–128.

    Article  CAS  PubMed  Google Scholar 

  60. Galletly C, Clark A, Tomlinson L, Blaney F. Improved pregnancy rates for obese, infertile women following a group treatment program. An open pilot study. Gen Hosp Psychiatry 1996;18:192–195.

    Article  CAS  PubMed  Google Scholar 

  61. Augood C, Duckitt K, Templeton A. Smoking and female infertility: a systematic review and metaanalysis. Hum Reprod 1998;13:532–539.

    Article  Google Scholar 

  62. Werler MM. Teratogen update: smoking and reproductive outcomes Teratology 1997;55:382–388.

    Article  CAS  PubMed  Google Scholar 

  63. Jahanfer S, Eden JA, Nguyent TV. Bulimia nervosa and polycystic ovary syndrome. Gynecol Endocrinol 1995;9:113–117.

    Article  Google Scholar 

  64. Norman RJ, Clark AM. Lifestyle factors in the aetiology and management of polycystic ovary syndrome. In: Kovacs GT, ed, Polycystic Ovary Syndrome. Cambridge: Cambridge University Press, 2000, pp. 98–116.

    Google Scholar 

  65. Norman RJ, Davies MJ, Lord J, Moran LJ. The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab 2002;13:251–257.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Centre for Reproductive Health and Repromed, The Queen Elizabeth Hospital, University of Adelaide, South Australia, Australia

    R. J. Norman BSc

  2. CSIRO Human Nutrition, South Australia, Australia

    L. J. Moran BSc, MBCHB, MD, FRACOG, FRACP

Authors
  1. R. J. Norman BSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. J. Moran BSc, MBCHB, MD, FRACOG, FRACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Endocrine Section of First Department of Internal Medicine, Athens University School of Medicine, Athens, Greece

    Evanthia Diamanti-Kandarakis MD, PhD

  2. Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA

    John E. Nestler MD

  3. Division of Endocrinology and Human Reproduction, Second Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Thessaloniki, Greece

    Dimitrios Panidis MD, PhD

  4. Endocrinology Unit, Department of Internal Medicine and Gastroenterology and C.R.B.A., S. Orsola-Malpighi Hospital, Alma Mater Studiorum University of Bologna, Bologna, Italy

    Renato Pasquali MD

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc.

About this chapter

Cite this chapter

Norman, R.J., Moran, L.J. (2007). Diet and Lifestyle Factors in the Etiology and Management of Polycystic Ovary Syndrome. In: Diamanti-Kandarakis, E., Nestler, J.E., Panidis, D., Pasquali, R. (eds) Insulin Resistance and Polycystic Ovarian Syndrome. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-59745-310-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-310-3_11

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-763-1

  • Online ISBN: 978-1-59745-310-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation